Targeting the Myeloid Lineages and the Immune Microenvironment in Myelodysplastic Syndromes: Novel and Evolving Therapeutic Strategies

CONCLUSION: The development of novel and investigational therapeutic agents continues to contribute to an improved understanding of tumor biology. The precise therapeutic role and timing of these agents remain to be elucidated.PMID:34330162 | DOI:10.1177/10600280211036154

Source: The Annals of Pharmacotherapy - July 31, 2021 Category: Drugs & Pharmacology Authors: Clement Chung Source Type: research